Erich Brunn welcomes promotion
Takeda Pharmaceutical Company has appointed Dr Erich Brunn as ceo of Takeda Pharmaceuticals Europe, a wholly owned subsidiary for oversight of pan-European sales & marketing.
Takeda Pharmaceutical Company has appointed Dr Erich Brunn as ceo of Takeda Pharmaceuticals Europe, a wholly owned subsidiary for oversight of pan-European sales & marketing.
Brunn has a doctorate in chemistry and, since 2001, has been president of Takeda Pharma, a wholly owned subsidiary of Takeda in Germany, having also previously worked at Upjohn GmbH, Pharmacia & Upjohn GmbH and Pharmacia GmbH in various functions.
"Dr Brunn has a proven track record of success and excellence, which is apparent through the remarkable growth achieved by Takeda Pharma GmbH under his leadership," said Yasuchika Hasegawa, president of Takeda. "We are confident that he will provide TPEU with the same level of success as he takes on this pivotal role as CEO of TPEU."
"I am pleased to accept this exciting challenge to lead TPEU, which is a core organisation for Takeda's operations in Europe," said Brunn. "Through this role, I am determined to further enhance Takeda's business foundation in Europe."
